Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Tailored anti-biofilm activity – Liposomal delivery for mimic of small antimicrobial peptide (CROSBI ID 325602)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Hemmingsen, Lisa Myrseth ; Giordani, Barbara ; Paulsen, Marianne H. ; Vanić, Željka ; Flaten, Gøril Eide ; Vitali, Beatrice ; Basnet, Purusotam ; Bayer, Annette ; Strøm, Morten B. ; Škalko-Basnet, Nataša Tailored anti-biofilm activity – Liposomal delivery for mimic of small antimicrobial peptide Biomaterials Advances, 145 (2023), 1-16

Podaci o odgovornosti

Hemmingsen, Lisa Myrseth ; Giordani, Barbara ; Paulsen, Marianne H. ; Vanić, Željka ; Flaten, Gøril Eide ; Vitali, Beatrice ; Basnet, Purusotam ; Bayer, Annette ; Strøm, Morten B. ; Škalko-Basnet, Nataša

engleski

Tailored anti-biofilm activity – Liposomal delivery for mimic of small antimicrobial peptide

The eradication of bacteria embedded in biofilms is among the most challenging obstacles in the management of chronic wounds. These biofilms are found in most chronic wounds ; moreover, the biofilm-embedded bacteria are considerably less susceptible to conventional antimicrobial treatment than the planktonic bacteria. Antimicrobial peptides and their mimics are considered attractive candidates in the pursuit of novel therapeutic options for the treatment of chronic wounds and general bacterial eradication. However, some limitations linked to these membrane-active antimicrobials are making their clinical use challenging. Novel innovative delivery systems addressing these limitations represent a smart solution. We hypothesized that incorporation of a novel synthetic mimic of an antimicrobial peptide in liposomes could improve its anti-biofilm effect as well as the antiinflammatory activity. The small synthetic mimic of an antimicrobial peptide, 7e-SMAMP, was incorporated into liposomes (~280 nm) tailored for skin wounds and evaluated for its potential activity against both biofilm formation and eradication of pre-formed biofilms. The 7e-SMAMP-liposomes significantly lowered inflammatory response in murine macrophages (~30 % reduction) without affecting the viability of macrophages or keratinocytes. Importantly, the 7e-SMAMP-liposomes completely eradicated biofilms produced by Staphylococcus aureus and Escherichia coli above concentrations of 6.25 μg/mL, whereas in Pseudomonas aeruginosa the eradication reached 75 % at the same concentration. Incorporation of 7e-SMAMP in liposomes improved both the inhibition of biofilm formation as well as biofilm eradication in vitro, as compared to non- formulated antimicrobial, therefore confirming its potential as a novel therapeutic option for bacteria-infected chronic wounds.

Peptidomimetics ; Liposomes ; Bacterial biofilms ; Membrane-active antimicrobials ; Chronic wounds

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

145

2023.

1-16

objavljeno

2772-9508

2772-9508

Povezanost rada

Farmacija

Indeksiranost